Evidence map›Paper›PMID 42883314›Full record

ArticleMolecules (Basel, Switzerland)2026

Synthesis, Biological Evaluation, and Molecular Docking of Pyridine-Containing Squaramides as DNase I Inhibitors.

Mariyana Atanasova, Nina Ruseva, Georgi Tirolski, Simeon Stoyanov, Ana Marković, Andrija Šmelcerović, Magdalena Angelova, Hristina Sbirkova-Dimitrova, Adriana Bakalova, Rositsa Mihaylova and 1 more

Abstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Mariyana AtanasovaDepartment of Chemistry, Faculty of Pharmacy, Medical University of Sofia, 2 Dunav Str., 1000 Sofia, Bulgaria.ORCID 0000-0001-9761-0355
Nina RusevaDepartment of General and Inorganic Chemistry, University of Chemical Technology and Metallurgy, 1756 Sofia, Bulgaria.
Georgi TirolskiInstitute of Organic Chemistry with Centre of Phytochemistry, Bulgarian Academy of Sciences, Acad. G. Bontchev Str., Bl. 9, 1113 Sofia, Bulgaria.
Simeon StoyanovInstitute of Organic Chemistry with Centre of Phytochemistry, Bulgarian Academy of Sciences, Acad. G. Bontchev Str., Bl. 9, 1113 Sofia, Bulgaria.
Ana MarkovićDepartment of Pharmacy, Faculty of Medicine, University of Niš, Blvd. Dr Zorana Đinđića 81, 18000 Niš, Serbia.
Andrija ŠmelcerovićDepartment of Chemistry, Faculty of Medicine, University of Niš, Blvd. Dr Zorana Đinđića 81, 18000 Niš, Serbia.ORCID 0000-0001-7724-0967
Magdalena AngelovaInstitute of Mineralogy and Crystallography, "Akad. Ivan Kostov", Bulgarian Academy of Sciences, Acad. Georgi Bonchev Str., Bl. 107, 1113 Sofia, Bulgaria.
Hristina Sbirkova-DimitrovaInstitute of Mineralogy and Crystallography, "Akad. Ivan Kostov", Bulgarian Academy of Sciences, Acad. Georgi Bonchev Str., Bl. 107, 1113 Sofia, Bulgaria.
Adriana BakalovaDepartment of Chemistry, Faculty of Pharmacy, Medical University of Sofia, 2 Dunav Str., 1000 Sofia, Bulgaria.ORCID 0000-0002-3017-3258
Rositsa MihaylovaCentre of Excellence in Informatics and Information and Communication Technologies, Bulgarian Academy of Sciences, Akad. Georgi Bonchev Str., Block 2 and 25A, 1113 Sofia, Bulgaria.ORCID 0000-0001-5763-0730
Emiliya ChernevaDepartment of Chemistry, Faculty of Pharmacy, Medical University of Sofia, 2 Dunav Str., 1000 Sofia, Bulgaria.ORCID 0000-0002-1097-1850

Funding

Bulgarian Science Fund KP06-Kitai/6European Union BG16RFPR002-1.014-0007Ministry of Science, Technological Development, and Innovation 451-03-137/2025-03/200113
6 · The paper itself

Abstract

backgroundDNase I inhibitors may be useful as biochemical tools and as potential leads for investigating pathological processes associated with excessive DNA degradation. Squaramides represent attractive scaffolds for drug discovery owing to their rigid, highly polarized structure and versatile hydrogen-bonding properties.

methodsFour novel pyridine-containing squaramides (

resultsAll compounds inhibited bovine pancreatic DNase I, with IC

conclusionsPyridine-containing squaramides represent a promising scaffold for further investigation as DNase I inhibitors, with

Indexed as

CyclobutanesDeoxyribonuclease IEnzyme InhibitorsMolecular Docking SimulationPyridinesQuinolinesAnimalsCattleCell Line, TumorHumansMolecular StructureQuinineStructure-Activity RelationshipCyclobutanesDeoxyribonuclease IEnzyme InhibitorspyridinePyridinesQuinineQuinolinessquaramideDNase I inhibitorsenzyme inhibitionmolecular dockingpyridine-containing compoundssquaramides

Identifiers

PMID42883314
PMCPMC13667282

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.